90 related articles for article (PubMed ID: 15177304)
1. The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
Al-Ayadhi LY; Al-Tuwajri AS
Pharmacol Res; 2004 Aug; 50(2):157-63. PubMed ID: 15177304
[TBL] [Abstract][Full Text] [Related]
2. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD.
Jones NA; Leport M; Holand T; Vos T; Morgan M; Fink M; Pruniaux MP; Berthelier C; O'Connor BJ; Bertrand C; Page CP
Pulm Pharmacol Ther; 2007; 20(1):60-8. PubMed ID: 16427796
[TBL] [Abstract][Full Text] [Related]
4. Effects of SCA40 on human isolated bronchus and human polymorphonuclear leukocytes: comparison with rolipram, SKF94120 and levcromakalim.
Cortijo J; Villagrasa V; Navarrete C; Sanz C; Berto L; Michel A; Bonnet PA; Morcillo EJ
Br J Pharmacol; 1996 Sep; 119(1):99-106. PubMed ID: 8872362
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram.
Sullivan GW; Linden J; Buster BL; Scheld WM
J Infect Dis; 1999 Nov; 180(5):1550-60. PubMed ID: 10515815
[TBL] [Abstract][Full Text] [Related]
6. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
Chang YH; Conti M; Lee YC; Lai HL; Ching YH; Chern Y
J Neurochem; 1997 Sep; 69(3):1300-9. PubMed ID: 9282956
[TBL] [Abstract][Full Text] [Related]
7. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
Blease K; Burke-Gaffney A; Hellewell PG
Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
[TBL] [Abstract][Full Text] [Related]
8. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.
Steel HC; Anderson R
Br J Pharmacol; 2002 May; 136(1):81-9. PubMed ID: 11976271
[TBL] [Abstract][Full Text] [Related]
10. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV.
Chini CC; Chini EN; Williams JM; Matousovic K; Dousa TP
Kidney Int; 1994 Jul; 46(1):28-36. PubMed ID: 7933846
[TBL] [Abstract][Full Text] [Related]
11. Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
Silva PM; Alves AC; Serra MF; Pires AL; Silva JP; Barreto EO; Cordeiro RS; Jose PJ; Teixeira MM; Lagente V; Martins MA
Br J Pharmacol; 2001 Sep; 134(2):283-94. PubMed ID: 11564646
[TBL] [Abstract][Full Text] [Related]
12. The specific type IV phosphodiesterase inhibitor rolipram combined with adenosine reduces tumor necrosis factor-alpha-primed neutrophil oxidative activity.
Sullivan GW; Carper HT; Mandell GL
Int J Immunopharmacol; 1995 Oct; 17(10):793-803. PubMed ID: 8707444
[TBL] [Abstract][Full Text] [Related]
13. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils.
Kyoi T; Noda K; Oka M; Ukai Y
Life Sci; 2004 Nov; 76(1):71-83. PubMed ID: 15501481
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
Villagrasa V; Navarrete C; Sanz C; Berto L; Perpiñá M; Cortijo J; Morcillo EJ
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):239-45. PubMed ID: 8803956
[TBL] [Abstract][Full Text] [Related]
15. Effects of stimulation of adenosine A2A receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Murray TF
Am J Vet Res; 2007 Jun; 68(6):649-56. PubMed ID: 17542699
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the adenosine A2A receptor-induced sensitization of esophageal C fibers.
Brozmanova M; Mazurova L; Ru F; Tatar M; Hu Y; Yu S; Kollarik M
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G215-23. PubMed ID: 26564719
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms for desensitization of A2a adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells.
Chern Y; Lai HL; Fong JC; Liang Y
Mol Pharmacol; 1993 Nov; 44(5):950-8. PubMed ID: 8246918
[TBL] [Abstract][Full Text] [Related]
18. Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury.
Souza DG; Cassali GD; Poole S; Teixeira MM
Br J Pharmacol; 2001 Nov; 134(5):985-94. PubMed ID: 11682446
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chemotactic peptide-induced neutrophil adhesion to vascular endothelium by cAMP modulators.
Derian CK; Santulli RJ; Rao PE; Solomon HF; Barrett JA
J Immunol; 1995 Jan; 154(1):308-17. PubMed ID: 7995950
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
